Literature DB >> 14661897

Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery.

Tamer Demir1, Burak Turgut, Ulku Celiker, Ibrahim Ozercan, Fatih Ulas, Nuray Akyol.   

Abstract

Wound healing affects the success of glaucoma filtering surgery. Antimetabolites and antifibrotic agents are used in the modulation of surgical trauma. This study is performed to evaluate the effects of amniotic membrane and octreotide acetate on wound healing. Thirty pigmented rabbits were divided into three groups each including 10 animals. Trabeculectomy and topical postoperative prednisolone sodium phosphate four times daily for 7 days were applied to one eye of all the rabbits. After trabeculectomy, octreotide 10 microg three times daily applied topically to the octreotide group for 14 days and amniotic membrane transplantation was performed by suturing amniotic membrane between scleral flap and sclera to the amniotic membrane group. The operated eyes of the rabbits were enucleated on the 14th day of the operation and histopathological specimens were obtained from the bleb sites and they were evaluated by light microscope. Fibroblast and macrophage number per cm2 were counted and the average values were calculated. Compared with the control group, the fibroblasts and macrophages significantly decreased in the other two groups (p < 0.0001, p < 0.0001, respectively). The mean number of fibroblasts was lower than those of the control and amniotic membrane groups (p < 0.0001, p < 0.0001, respectively). Similarly the mean macrophage number was significantly lower in the octreotide group versus the control and amniotic membrane groups (p < 0.0001, p < 0.01, respectively). Octreotide administration and amniotic membrane transplantation might be alternative treatments in modulating the wound healing after trabeculectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661897     DOI: 10.1023/a:1026257227194

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  41 in total

1.  Antibacterial properties of human amniotic membranes.

Authors:  Y P Talmi; L Sigler; E Inge; Y Finkelstein; Y Zohar
Journal:  Placenta       Date:  1991 May-Jun       Impact factor: 3.481

2.  Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts.

Authors:  S Saika; O Yamanaka; Y Baba; Y Kawashima; K Shirai; T Miyamoto; Y Okada; Y Ohnishi; A Ooshima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-03       Impact factor: 3.117

3.  Healing of trabeculectomies in rabbits.

Authors:  A Seetner; J D Morin
Journal:  Can J Ophthalmol       Date:  1979-04       Impact factor: 1.882

4.  Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells.

Authors:  M Adinolfi; C A Akle; I McColl; A H Fensom; L Tansley; P Connolly; B L Hsi; W P Faulk; P Travers; W F Bodmer
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

5.  Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2.

Authors:  R C Tripathi; J Li; W F Chan; B J Tripathi
Journal:  Exp Eye Res       Date:  1994-12       Impact factor: 3.467

6.  Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair.

Authors:  J H Levine; H L Moses; L I Gold; L B Nanney
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Aberrant levels of cytokines within the healing wound after burn injury.

Authors:  N Pejnović; D Lilić; G Zunić; M Colić; M Kataranovski; A Dujić
Journal:  Arch Surg       Date:  1995-09

8.  Effects of systemic octreotide, local mytomycine-C and local corticosteroids on wound-healing reaction after glaucoma surgery.

Authors:  N Akyol; T Demir; A Kükner; N Colakoğlu
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

9.  Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).

Authors:  R Danesi; C Agen; U Benelli; A D Paolo; D Nardini; G Bocci; F Basolo; A Campagni; M D Tacca
Journal:  Clin Cancer Res       Date:  1997-02       Impact factor: 12.531

10.  Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.

Authors:  N Boudreau; C J Sympson; Z Werb; M J Bissell
Journal:  Science       Date:  1995-02-10       Impact factor: 47.728

View more
  7 in total

1.  Comparison of trabeculectomy and trabeculectomy with amniotic membrane transplantation in the same patient with bilateral glaucoma.

Authors:  Qing-Shan Ji; Bing Qi; Lian Liu; Wei Lao; Zhi-Hao Yang; Gui-Fang Wang; Guo-Cheng Yu; Jing-Xiang Zhong
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study.

Authors:  Shashi Kumar Bhasker; Sandeep Saxena; Kamlesh Singh
Journal:  J Ocul Biol Dis Infor       Date:  2013-06-27

3.  Effects of Honghua preserved amniotic membrane on scar healing in experimental glaucoma surgery.

Authors:  Yi Shao; Yao Yu; Qiu-Ping Liu; Jing-Ming Li; Fei Dong; Xin Huang; Chong-Gang Pei; Ping Tu; Hen-Hui Li; Gui-Ping Gao
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

4.  Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series.

Authors:  Jin Young Choi; Jaewan Choi; Yeon-Deok Kim
Journal:  Korean J Ophthalmol       Date:  2010-02-05

5.  Ciliary body toxicity of cyclosporin A and octreotide acetate in rabbit eyes: a comparison with mitomycin C and 5-fluorouracil.

Authors:  Nuray Akyol; Tamer Demir; Bengu Cobanoglu; Fatih Ulaş
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-09       Impact factor: 3.117

6.  The use of amniotic membrane in trabeculectomy for the treatment of primary open-angle glaucoma: a prospective study.

Authors:  Panagiotis Stavrakas; Gerasimos Georgopoulos; Maria Milia; Dimitris Papaconstantinou; Maria Bafa; Efthymios Stavrakas; Mihalis Moschos
Journal:  Clin Ophthalmol       Date:  2012-02-02

7.  The impact of octreotide in experimental proliferative vitreoretinopathy.

Authors:  Ozge Evren; Burak Turgut; Ulku Celiker; Kadir Ates
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.